Moli, Maxima T.
HRN: 21-29-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/30/2022
05/07/2022
IV
1.5g
Q6hrs
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes